Case Study – Biosecurity and Chain-of-Custody Verification
By Dr Neil Williamson – NW Bio-X Ltd Strain identity and protocol traceability, addressed in the two case studies above, primarily protect an organisation’s own record of its R&D investment. A third dimension of the provenance problem is external: demonstrating to a regulator, a commercial partner, or the public that a specific organism is what […]
Case Study – Version Controlling a CRISPR-Cas9 editing protocol
By Dr Neil Williamson from NW Bio-X Limited Strain identity is one half of the data management problem. The other is the protocol itself: the method that must perform consistently regardless of who runs it, which reagents they use, or which instrument they work on. The composite illustrative case study below demonstrates that CellRepo has […]
Case Study – Strain development from pathway to CDMO scale-up
By Dr Neil Williamson from NW Bio-X Limited The operational impact of data management failures is most clearly traced through a real engineering biology workflow. The composite illustrative case study below is based on common patterns observed across multiple engineering biology organisations. It does not represent any single company or project. Composite Illustrative Case Study […]